FCA
FinTrust Capital Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $8.46K | Hold |
180
| – | – | ﹤0.01% | 968 |
|
|
2024
Q2 | $9.72K | Hold |
180
| – | – | ﹤0.01% | 884 |
|
|
2024
Q1 | $12.3K | Hold |
180
| – | – | ﹤0.01% | 805 |
|
|
2023
Q4 | $11.3K | Hold |
180
| – | – | ﹤0.01% | 787 |
|
|
2023
Q3 | $8.17K | Sell |
180
-377
| -68% | -$17.1K | ﹤0.01% | 804 |
|
|
2023
Q2 | $22.6K | Hold |
557
| – | – | 0.01% | 617 |
|
|
2023
Q1 | $22.6K | Hold |
557
| – | – | 0.01% | 616 |
|
|
2022
Q4 | $22.6K | Hold |
557
| – | – | 0.01% | 616 |
|
|
2022
Q3 | $32K | Sell |
557
-402
| -42% | -$23.1K | 0.01% | 603 |
|
|
2022
Q2 | $73K | Hold |
959
| – | – | 0.02% | 458 |
|
|
2022
Q1 | $60K | Sell |
959
-26,984
| -97% | -$1.69M | 0.01% | 521 |
|
|
2021
Q4 | $2.12M | Buy |
27,943
+2,161
| +8% | +$164K | 0.51% | 47 |
|
|
2021
Q3 | $2.89M | Sell |
25,782
-210
| -0.8% | -$23.5K | 0.76% | 29 |
|
|
2021
Q2 | $4.21M | Buy |
25,992
+1,159
| +5% | +$188K | 1.1% | 15 |
|
|
2021
Q1 | $3.03M | Sell |
24,833
-396
| -2% | -$48.3K | 0.87% | 21 |
|
|
2020
Q4 | $3.86M | Buy |
25,229
+801
| +3% | +$123K | 1.23% | 12 |
|
|
2020
Q3 | $2.04K | Sell |
24,428
-1,721
| -7% | -$144 | 0.4% | 34 |
|
|
2020
Q2 | $1.92M | Buy |
26,149
+25,014
| +2,204% | +$1.84M | 0.76% | 34 |
|
|
2020
Q1 | $48K | Sell |
1,135
-100
| -8% | -$4.23K | 0.02% | 439 |
|
|
2019
Q4 | $75K | Hold |
1,235
| – | – | 0.03% | 366 |
|
|
2019
Q3 | $51K | Buy |
+1,235
| New | +$51K | 0.02% | 423 |
|